A carregar...
Ketamine: Leading us into the future for development of antidepressants
Numerous randomized double-blind clinical trials have consistently shown that that a single intravenous administration of a subanesthetic dose of ketamine to treatment-resistant depressed patients significantly improved depressive symptomatology rapidly, within two hours, with the effect lasting up...
Na minha lista:
| Publicado no: | Behav Brain Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7890296/ https://ncbi.nlm.nih.gov/pubmed/32023492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbr.2020.112532 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|